Fundz

Versameb Appoints Professor Roger Dmochowski as Chief Medical Officer

PRIVATEJun 21, 2023

Position

Chief Medical Officer

Company

Versameb

Roger Dmochowski
roger.dmochowski@versameb.com
BaselBiotechnologyHealth CareTherapeutics

Description

Versameb AG , a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, is pleased to announce the appointment of Professor Roger Dmochowski as Chief Medical Officer with immediate effect.

Quick answer

Versameb Appoints Professor Roger Dmochowski as Chief Medical Officer (June 21, 2023). Versameb is based in Basel, Basel City, Switzerland.

Who is the new Chief Medical Officer at Versameb?
Versameb named Roger Dmochowski Chief Medical Officer, announced June 21, 2023.
What did Versameb announce on June 21, 2023?
Versameb AG , a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, is pleased to announce the appointment of Professor Roger Dmochowski as Chief Medical Officer with immediate effect.
What does Versameb do?
Versameb AG is a privately held biotechnology company focusing on discovering and developing innovative RNA-based drugs for modulation of protein expression, including the ability to simultaneously influence several...
Where is Versameb based?
Versameb is based in Basel, Basel City, Switzerland.
Which similar companies made leadership changes around the same time?
BIOCEPT INC (June 20, 2023), Virpax Pharmaceuticals (June 20, 2023), Tenet Healthcare (June 23, 2023) and Bicycle Therapeutics (June 23, 2023) also announced leadership changes within 45 days of Versameb.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Versameb, and when

A new leader at Versameb brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Versameb raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Versameb, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Versameb. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Versameb

Location

Basel, Basel City, Switzerland

About

Versameb AG is a privately held biotechnology company focusing on discovering and developing innovative RNA-based drugs for modulation of protein expression, including the ability to simultaneously influence several therapeutic targets, in a controlled manner, with one molecular construct, and cellular targeting. Based in Basel and fully operational from 2018, the company is led by an experienced scientific and leadership team with proven expertise in drug discovery and development from lab bench to patient. Versameb's proprietary technology platform, VERSagile, optimizes the application of functional RNA in different disease contexts – making RNA druggable in new therapeutic areas others have been unable to solve. The pipeline includes lead candidate programs in Stress Urinary Incontinence (SUI) and solid tumors. Versameb is working towards the completion of a first in-human/proof-of-concept clinical study while advancing its platform. More information on Versameb can be found at www.versameb.com as well as on LinkedIn. SOURCE Versameb

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Versameb changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Roger
Likely contact at this company
••••••••@••••••••

See Roger's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Versameb's next move

Learn about Strategic plan

Versameb changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.